F19.259
Other psychoactive substance dependence with psychoactive substance-induced psychotic disorder, unspecified
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 code F19.259 refers to a condition where an individual has developed a dependence on a psychoactive substance, which has led to a psychotic disorder caused directly by the substance. This condition indicates significant mental health challenges characterized by psychosis symptoms such as hallucinations or delusions that are induced by the prolonged or abusive use of various psychoactive drugs. It is classified as 'unspecified,' meaning it encompasses cases where specific details about the psychotic disorder have not been fully determined or documented. Recognizing and understanding this condition is crucial for appropriate management and support.
Causes & Symptoms
Clinical Causes: Chronic or heavy use of psychoactive substances such as stimulants, hallucinogens, or certain prescription medications. Prolonged exposure to substances that significantly alter brain chemistry and functioning. Genetic predisposition to mental health disorders that can be exacerbated by substance use. Co-occurring mental health conditions which may increase the risk of developing substance dependence and psychosis.
Key Symptoms: Hallucinations, which may involve hearing voices or seeing things that aren't there. Delusional beliefs or false fixed ideas that are resistant to reason or contrary evidence. Disorganized thinking, making it difficult to follow conversations or make logical decisions. Severe agitation or restlessness. Paranoia or intense feelings of suspicion. Changes in behavior such as social withdrawal or unusual activities. Physical symptoms like tremors or altered consciousness in severe cases. Mood disturbances including anxiety, paranoia, or depression.
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a comprehensive assessment by a mental health professional or psychiatrist, including detailed clinical interviews. Medical history focusing on substance use, duration, and patterns is essential. Diagnostic criteria from ICD-10 guide the clinician to identify dependence on psychoactive substances combined with evidence of psychotic episodes induced or exacerbated by substance use. Additional investigations may include laboratory tests, toxicology screening, and mental status examinations to support the diagnosis and rule out other causes of psychosis.
Treatment Protocols: Detoxification programs to safely manage withdrawal symptoms. Medication to address psychotic symptoms, such as antipsychotics, under professional supervision. Psychotherapy approaches including cognitive-behavioral therapy (CBT) to help modify thought patterns and behaviors. Support groups and counseling to encourage cessation of substance use and provide social assistance. Monitoring and treatment for any co-occurring mental health conditions. Relapse prevention programs and long-term follow-up to maintain sobriety and stability.
Clinical Advice & FAQs
Billing Guidance
Is F19.259 a billable ICD-10 code?
Yes, F19.259 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F19.259?
Clinical documentation must specify the nature of Other psychoactive substance dependence with psychoactive substance-induced psychotic disorder, unspecified and any associated comorbidities for accurate reporting.
Cite this Clinical Reference